查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1641728

全球細胞遺傳學市場按產品、技術、應用和最終用戶分類 - 機會分析和產業預測（2024-2035 年）

Cytogenetics Market By Product, By Technique, By Application, By End User : Global Opportunity Analysis and Industry Forecast, 2024-2035
出版日期: | 出版商: Allied Market Research | 英文 322 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計 2023 年細胞遺傳學市場價值為 28.094 億美元，到 2035 年將達到 106.2705 億美元，2024 年至 2035 年的複合年成長率為 11.7%。

細胞遺傳學市場-IMG1

細胞遺傳學是遺傳學的一個分支，主要研究染色體，即細胞內含有 DNA 的結構。分析染色體的數量、結構和行為，以了解它們在遺傳、疾病和生物功能中的作用。細胞遺傳學技術，例如核型分析、螢光原位雜合反應(FISH) 和比較基因組雜合反應(CGH) 可以識別染色體異常，例如缺失、重複、易位和非整倍體。這些異常與多種遺傳性疾病、癌症和先天性疾病有關。透過檢查細胞的染色體組成，細胞遺傳學在產前檢測、癌症研究、遺傳諮詢和個人化醫療中發揮重要作用。這個領域連結了傳統遺傳學和現代分子生物學，深入了解染色體層面的變化如何影響個人健康和研究，加速臨床和研究的進步。

推動細胞遺傳學市場成長的主要因素是全球遺傳疾病和癌症的發生率不斷上升，從而刺激了對細胞遺傳學檢測和診斷的需求。隨著唐氏症等遺傳性疾病和各種癌症變得越來越普遍，對準確、早期檢測方法的需求也顯著增加。細胞遺傳學技術，例如核型分析、螢光原位雜合反應(FISH) 和染色體微陣列分析(CMA)，對於識別與這些疾病相關的染色體異常至關重要，從而推動市場成長。 。

然而，細胞遺傳學技術高成本，包括設備和專業知識，可能令人望而卻步，尤其是在低收入和中等收入國家，這限制了人們獲得先進診斷工具的機會。此外，細胞遺傳學程序的複雜性需要熟練的專業人員和專門的培訓，而某些地區卻供不應求，進一步限制了市場的成長。另一方面，個人化醫療的需求不斷成長，這在很大程度上依賴先進的基因檢測來根據個別患者的基因特徵制定治療方案，而新興國家的高成長潛力正在為市場擴張創造機會。

細胞遺傳學市場分為產品、技術、應用、最終用戶和地區。根據產品類型，該部門分為消耗品、設備、軟體和服務。消耗品部分進一步分為檢測套組和試劑、培養基、探針等。培養基部分也包括血清培養基等。根據技術，市場分為比較雜合反應、螢光原位雜合反應、核型分析和其他。核型分析又分為產前檢測、癌症和其他。產前檢測部分分為消耗品、設備、軟體和服務。腫瘤學領域進一步分為消耗品，包括檢測套組、試劑和培養基。其餘歸類為消耗品，包括檢測套組、試劑和培養基。

依應用分為遺傳疾病、癌症、個人化醫療和其他。根據最終用戶，市場分為臨床/研究機構、製藥/生技公司、學術研究機構等。依地區分類，市場分為北美（美國、加拿大、墨西哥）、歐洲（德國、法國、英國、義大利、西班牙等）、亞太地區（日本、中國、印度、澳洲、韓國等） )、拉丁美洲和中東- 調查將在非洲（巴西、南非、沙烏地阿拉伯等）進行。

相關人員的主要利益

  • 該報告對 2023 年至 2035 年細胞遺傳學市場分析的市場細分、當前趨勢、估計、趨勢和動態進行了定量分析，並確定了細胞遺傳學市場中的突出機會。
  • 它為市場研究提供與市場促進因素、市場限制因素和市場機會相關的資訊。
  • 波特五力分析強調了買家和供應商的潛力，幫助相關人員做出利潤驅動的商業決策，並加強供應商-買家網路。
  • 對細胞遺傳學市場細分的詳細分析有助於確定市場機會。
  • 每個地區的主要國家都根據收益貢獻進行分類。
  • 市場公司的定位有利於基準化分析，並能清楚了解市場公司的當前地位。
  • 報告包括對區域和全球細胞遺傳學市場趨勢、主要企業、細分市場、應用領域和市場成長策略的分析。

本報告中提供的自訂功能

  • 監管指南
  • 根據客戶興趣加入公司簡介
  • 擴展公司簡介列表
  • 歷史市場資料

目錄

第 1 章 簡介

第 2 章執行摘要

第3章 市場概況

  • 市場定義和範圍
  • 主要發現
    • 影響因素
    • 主要投資機會
  • 波特五力分析
  • 市場動態
    • 驅動程式
      • 遺傳疾病盛行率不斷上升
      • 提高對個人化醫療的認知與採用
      • 技術進步
    • 限制因素
      • 設備和程序成本高昂
    • 機會
      • 更加重視研發
      • 新興國家高成長潛力

第4章 細胞遺傳學市場（按產品）

  • 概述
  • 耗材
  • 裝置
  • 軟體和服務

5. 細胞遺傳學市場（依技術分類）

  • 概述
  • 比較雜合反應
  • 螢光原位雜合反應
  • 核型分析
  • 其他

第6章 細胞遺傳學市場（按應用）

  • 概述
  • 遺傳性疾病
  • 癌症
  • 個人化醫療
  • 其他

7. 細胞遺傳學市場（依最終用戶分類）

  • 概述
  • 臨床研究所
  • 製藥和生物技術公司
  • 學術研究所
  • 其他

8. 細胞遺傳學市場（按地區）

  • 概述
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 其他
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 其他
  • 拉丁美洲、中東和非洲
    • 巴西
    • 南非
    • 沙烏地阿拉伯
    • 其他

第9章 競爭格局

  • 介紹
  • 關鍵成功策略
  • 前 10 家公司的產品映射
  • 競爭儀錶板
  • 競爭熱圖
  • 主要企業定位（2023年）

第10章 公司簡介

  • PAN-Biotech
  • Precipio, Inc.
  • Applied Spectral Imaging
  • Capricorn Scientific
  • Thermo Fisher Scientific Inc.
  • AddLife
簡介目錄
Product Code: A01786

The cytogenetics market was valued at $2,809.40 million in 2023 and is estimated to reach $10,627.05 million by 2035, exhibiting a CAGR of 11.7% from 2024 to 2035.

Cytogenetics Market - IMG1

Cytogenetics is a branch of genetics focused on the study of chromosomes, the structures within cells that contain DNA. It involves analyzing the number, structure, and behavior of chromosomes to understand their role in heredity, disease, and biological function. Techniques in cytogenetics, such as karyotyping, fluorescence in situ hybridization (FISH), and comparative genomic hybridization (CGH), allow scientists to identify chromosomal abnormalities, such as deletions, duplications, translocations, and aneuploidies. These abnormalities are linked to various genetic disorders, cancers, and congenital conditions. By examining the chromosomal makeup of cells, cytogenetics plays a crucial role in prenatal diagnosis, cancer research, genetic counseling, and personalized medicine. The field bridges classical genetics with modern molecular biology, offering insights into how changes at the chromosomal level can affect an individual's health and development, making it an essential tool in both clinical and research settings.

The major factors that drive the growth of cytogenetics market include the rise in prevalence of genetic disorders and cancer globally which fuels demand for cytogenetic testing and diagnostics. As genetic conditions such as Down syndrome, and various types of cancer become more prevalent, the need for accurate and early detection methods has grown significantly. Cytogenetic techniques, including karyotyping, fluorescence in situ hybridization (FISH), and chromosomal microarray analysis (CMA), are essential for identifying chromosomal abnormalities associated with these conditions, thereby driving market growth.

However, the high cost associated with cytogenetic technologies, including equipment, and specialized expertise can be prohibitive, particularly in low- and middle-income countries, limiting access to advanced diagnostic tools and limiting the market growth. In addition, the complexity of cytogenetic procedures requires skilled professionals and specialized training, which can be scarce in certain regions, further constraining market growth. On the other hand, increase in demand for personalized medicine, which relies heavily on advanced genetic testing to tailor treatments to individual patients' genetic profiles and high growth potential in emerging countries create an opportunity for market expansion.

Cytogenetics market is categorized into product, technique, application, end user, and region. On the basis of the product, it is segmented into consumable, instrument, and software & service. The consumables segment is further classified into testing kits and reagents, media, probes, and others. Media segment further includes serum media and others. On the basis of technique, the market is segmented into comparative genome hybridization, fluorescence in situ hybridization, karyotyping, and others. The karyotyping segment further categorized into prenatal testing, cancer, and others. Prenatal testing segment categorized into consumable, instrument, and software & services. Cancer segment further categorized into consumables which includes testing kits and reagents and media. Others segment also categorized into consumables which includes testing kits and reagents and media.

On the basis of application, it is segmented into genetic disorders, cancer, personalized medicine, and others. On the basis of end user, the market is classified into clinical and research laboratory, pharmaceutical and biotechnology company, academic research institute, and others. Region-wise, the market is studied across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and Rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, Rest of LAMEA).

The major companies profiled in the report include PAN-Biotech, Precipio, Inc., Applied Spectral Imaging, Capricorn Scientific, AddLife, and Thermo Fisher Scientific Inc. The key players operating in the market have adopted partnership, joint venture, collaboration, and agreement as their key strategy to expand their product portfolio. For instance, in January 2024, Barco and Applied Spectral Imaging (ASI), a world leader in advanced biomedical imaging with a comprehensive product portfolio for karyotyping, H&E, IHC and FISH imaging and analysis, announced a new commercial partnership to offer best-in-class digital solutions for pathology laboratories

Key Benefits for Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the cytogenetics market analysis from 2023 to 2035 to identify the prevailing cytogenetics market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the cytogenetics market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global cytogenetics market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Expanded list for Company Profiles
  • Historic market data

Key Market Segments

By Product

  • Consumable
    • Type
    • Testing kits
    • Media

◦ Type

    • Probes
    • Others
  • Instrument
  • Software and service

By Technique

  • Comparitive genome hybridization
  • Fluorescence in situ hybridization
  • Karyotyping
    • Type
    • Prenatal Testing

◦ Type

    • Cancer

◦ Consumables

    • Others

◦ Consumable

  • Others

By Application

  • Genetic disorder
  • Cancer
  • Personalized medicine
  • Others

By End User

  • Clinical and research laboratory
    • Type
    • Cancer Research
    • Clinical Diagnostics Labs
    • Others
  • Pharmaceutical and biotechnology company
  • Academic Research Institute
  • Other

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa,
    • Saudi Arabia
    • Rest of LAMEA

Key Market Players:

    • AddLife
    • Applied Spectral Imaging
    • PAN-Biotech
    • Precipio, Inc.
    • Capricorn Scientific
    • Thermo Fisher Scientific Inc.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
    • 3.3.1. Moderate bargaining power of suppliers
    • 3.3.2. Moderate threat of new entrants
    • 3.3.3. Moderate threat of substitutes
    • 3.3.4. Moderate intensity of rivalry
    • 3.3.5. Moderate bargaining power of buyers
  • 3.4. Market dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Increase in prevalence of genetic disorders
      • 3.4.1.2. Increase in awareness and adoption of personalized medicine
      • 3.4.1.3. Advancement in technology
    • 3.4.2. Restraints
      • 3.4.2.1. High costs of equipment and procedures
    • 3.4.3. Opportunities
      • 3.4.3.1. Increase in focus on R&D
      • 3.4.3.2. High growth potential in emerging countries

CHAPTER 4: CYTOGENETICS MARKET, BY PRODUCT

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Consumable
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
    • 4.2.4. Consumable Cytogenetics Market by Type
      • 4.2.4.1. Media Cytogenetics Market by Type
  • 4.3. Instrument
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country
  • 4.4. Software and service
    • 4.4.1. Key market trends, growth factors and opportunities
    • 4.4.2. Market size and forecast, by region
    • 4.4.3. Market share analysis by country

CHAPTER 5: CYTOGENETICS MARKET, BY TECHNIQUE

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Comparitive genome hybridization
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Fluorescence in situ hybridization
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
  • 5.4. Karyotyping
    • 5.4.1. Key market trends, growth factors and opportunities
    • 5.4.2. Market size and forecast, by region
    • 5.4.3. Market share analysis by country
    • 5.4.4. Karyotyping Cytogenetics Market by Type
      • 5.4.4.1. Prenatal Testing Cytogenetics Market by Type
      • 5.4.4.1.1. Consumables Cytogenetics Market by Type
      • 5.4.4.2. Cancer Cytogenetics Market by Consumables
      • 5.4.4.2.1. Media Cytogenetics Market by Type
      • 5.4.4.3. Others Cytogenetics Market by Consumable
      • 5.4.4.3.1. Media Cytogenetics Market by Type
  • 5.5. Others
    • 5.5.1. Key market trends, growth factors and opportunities
    • 5.5.2. Market size and forecast, by region
    • 5.5.3. Market share analysis by country

CHAPTER 6: CYTOGENETICS MARKET, BY APPLICATION

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. Genetic disorder
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market share analysis by country
  • 6.3. Cancer
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market share analysis by country
  • 6.4. Personalized medicine
    • 6.4.1. Key market trends, growth factors and opportunities
    • 6.4.2. Market size and forecast, by region
    • 6.4.3. Market share analysis by country
  • 6.5. Others
    • 6.5.1. Key market trends, growth factors and opportunities
    • 6.5.2. Market size and forecast, by region
    • 6.5.3. Market share analysis by country

CHAPTER 7: CYTOGENETICS MARKET, BY END USER

  • 7.1. Overview
    • 7.1.1. Market size and forecast
  • 7.2. Clinical and research laboratory
    • 7.2.1. Key market trends, growth factors and opportunities
    • 7.2.2. Market size and forecast, by region
    • 7.2.3. Market share analysis by country
    • 7.2.4. Clinical and research laboratory Cytogenetics Market by Type
  • 7.3. Pharmaceutical and biotechnology company
    • 7.3.1. Key market trends, growth factors and opportunities
    • 7.3.2. Market size and forecast, by region
    • 7.3.3. Market share analysis by country
  • 7.4. Academic Research Institute
    • 7.4.1. Key market trends, growth factors and opportunities
    • 7.4.2. Market size and forecast, by region
    • 7.4.3. Market share analysis by country
  • 7.5. Other
    • 7.5.1. Key market trends, growth factors and opportunities
    • 7.5.2. Market size and forecast, by region
    • 7.5.3. Market share analysis by country

CHAPTER 8: CYTOGENETICS MARKET, BY REGION

  • 8.1. Overview
    • 8.1.1. Market size and forecast By Region
  • 8.2. North America
    • 8.2.1. Key market trends, growth factors and opportunities
    • 8.2.2. Market size and forecast, by Product
    • 8.2.3. Market size and forecast, by Technique
    • 8.2.4. Market size and forecast, by Application
    • 8.2.5. Market size and forecast, by End User
    • 8.2.6. Market size and forecast, by country
      • 8.2.6.1. U.S.
      • 8.2.6.1.1. Market size and forecast, by Product
      • 8.2.6.1.2. Market size and forecast, by Technique
      • 8.2.6.1.3. Market size and forecast, by Application
      • 8.2.6.1.4. Market size and forecast, by End User
      • 8.2.6.2. Canada
      • 8.2.6.2.1. Market size and forecast, by Product
      • 8.2.6.2.2. Market size and forecast, by Technique
      • 8.2.6.2.3. Market size and forecast, by Application
      • 8.2.6.2.4. Market size and forecast, by End User
      • 8.2.6.3. Mexico
      • 8.2.6.3.1. Market size and forecast, by Product
      • 8.2.6.3.2. Market size and forecast, by Technique
      • 8.2.6.3.3. Market size and forecast, by Application
      • 8.2.6.3.4. Market size and forecast, by End User
  • 8.3. Europe
    • 8.3.1. Key market trends, growth factors and opportunities
    • 8.3.2. Market size and forecast, by Product
    • 8.3.3. Market size and forecast, by Technique
    • 8.3.4. Market size and forecast, by Application
    • 8.3.5. Market size and forecast, by End User
    • 8.3.6. Market size and forecast, by country
      • 8.3.6.1. Germany
      • 8.3.6.1.1. Market size and forecast, by Product
      • 8.3.6.1.2. Market size and forecast, by Technique
      • 8.3.6.1.3. Market size and forecast, by Application
      • 8.3.6.1.4. Market size and forecast, by End User
      • 8.3.6.2. France
      • 8.3.6.2.1. Market size and forecast, by Product
      • 8.3.6.2.2. Market size and forecast, by Technique
      • 8.3.6.2.3. Market size and forecast, by Application
      • 8.3.6.2.4. Market size and forecast, by End User
      • 8.3.6.3. UK
      • 8.3.6.3.1. Market size and forecast, by Product
      • 8.3.6.3.2. Market size and forecast, by Technique
      • 8.3.6.3.3. Market size and forecast, by Application
      • 8.3.6.3.4. Market size and forecast, by End User
      • 8.3.6.4. Italy
      • 8.3.6.4.1. Market size and forecast, by Product
      • 8.3.6.4.2. Market size and forecast, by Technique
      • 8.3.6.4.3. Market size and forecast, by Application
      • 8.3.6.4.4. Market size and forecast, by End User
      • 8.3.6.5. Spain
      • 8.3.6.5.1. Market size and forecast, by Product
      • 8.3.6.5.2. Market size and forecast, by Technique
      • 8.3.6.5.3. Market size and forecast, by Application
      • 8.3.6.5.4. Market size and forecast, by End User
      • 8.3.6.6. Rest of Europe
      • 8.3.6.6.1. Market size and forecast, by Product
      • 8.3.6.6.2. Market size and forecast, by Technique
      • 8.3.6.6.3. Market size and forecast, by Application
      • 8.3.6.6.4. Market size and forecast, by End User
  • 8.4. Asia-Pacific
    • 8.4.1. Key market trends, growth factors and opportunities
    • 8.4.2. Market size and forecast, by Product
    • 8.4.3. Market size and forecast, by Technique
    • 8.4.4. Market size and forecast, by Application
    • 8.4.5. Market size and forecast, by End User
    • 8.4.6. Market size and forecast, by country
      • 8.4.6.1. Japan
      • 8.4.6.1.1. Market size and forecast, by Product
      • 8.4.6.1.2. Market size and forecast, by Technique
      • 8.4.6.1.3. Market size and forecast, by Application
      • 8.4.6.1.4. Market size and forecast, by End User
      • 8.4.6.2. China
      • 8.4.6.2.1. Market size and forecast, by Product
      • 8.4.6.2.2. Market size and forecast, by Technique
      • 8.4.6.2.3. Market size and forecast, by Application
      • 8.4.6.2.4. Market size and forecast, by End User
      • 8.4.6.3. India
      • 8.4.6.3.1. Market size and forecast, by Product
      • 8.4.6.3.2. Market size and forecast, by Technique
      • 8.4.6.3.3. Market size and forecast, by Application
      • 8.4.6.3.4. Market size and forecast, by End User
      • 8.4.6.4. Australia
      • 8.4.6.4.1. Market size and forecast, by Product
      • 8.4.6.4.2. Market size and forecast, by Technique
      • 8.4.6.4.3. Market size and forecast, by Application
      • 8.4.6.4.4. Market size and forecast, by End User
      • 8.4.6.5. South Korea
      • 8.4.6.5.1. Market size and forecast, by Product
      • 8.4.6.5.2. Market size and forecast, by Technique
      • 8.4.6.5.3. Market size and forecast, by Application
      • 8.4.6.5.4. Market size and forecast, by End User
      • 8.4.6.6. Rest of Asia-Pacific
      • 8.4.6.6.1. Market size and forecast, by Product
      • 8.4.6.6.2. Market size and forecast, by Technique
      • 8.4.6.6.3. Market size and forecast, by Application
      • 8.4.6.6.4. Market size and forecast, by End User
  • 8.5. LAMEA
    • 8.5.1. Key market trends, growth factors and opportunities
    • 8.5.2. Market size and forecast, by Product
    • 8.5.3. Market size and forecast, by Technique
    • 8.5.4. Market size and forecast, by Application
    • 8.5.5. Market size and forecast, by End User
    • 8.5.6. Market size and forecast, by country
      • 8.5.6.1. Brazil
      • 8.5.6.1.1. Market size and forecast, by Product
      • 8.5.6.1.2. Market size and forecast, by Technique
      • 8.5.6.1.3. Market size and forecast, by Application
      • 8.5.6.1.4. Market size and forecast, by End User
      • 8.5.6.2. South Africa,
      • 8.5.6.2.1. Market size and forecast, by Product
      • 8.5.6.2.2. Market size and forecast, by Technique
      • 8.5.6.2.3. Market size and forecast, by Application
      • 8.5.6.2.4. Market size and forecast, by End User
      • 8.5.6.3. Saudi Arabia
      • 8.5.6.3.1. Market size and forecast, by Product
      • 8.5.6.3.2. Market size and forecast, by Technique
      • 8.5.6.3.3. Market size and forecast, by Application
      • 8.5.6.3.4. Market size and forecast, by End User
      • 8.5.6.4. Rest of LAMEA
      • 8.5.6.4.1. Market size and forecast, by Product
      • 8.5.6.4.2. Market size and forecast, by Technique
      • 8.5.6.4.3. Market size and forecast, by Application
      • 8.5.6.4.4. Market size and forecast, by End User

CHAPTER 9: COMPETITIVE LANDSCAPE

  • 9.1. Introduction
  • 9.2. Top winning strategies
  • 9.3. Product mapping of top 10 player
  • 9.4. Competitive dashboard
  • 9.5. Competitive heatmap
  • 9.6. Top player positioning, 2023

CHAPTER 10: COMPANY PROFILES

  • 10.1. PAN-Biotech
    • 10.1.1. Company overview
    • 10.1.2. Key executives
    • 10.1.3. Company snapshot
    • 10.1.4. Operating business segments
    • 10.1.5. Product portfolio
  • 10.2. Precipio, Inc.
    • 10.2.1. Company overview
    • 10.2.2. Key executives
    • 10.2.3. Company snapshot
    • 10.2.4. Operating business segments
    • 10.2.5. Product portfolio
    • 10.2.6. Business performance
    • 10.2.7. Key strategic moves and developments
  • 10.3. Applied Spectral Imaging
    • 10.3.1. Company overview
    • 10.3.2. Key executives
    • 10.3.3. Company snapshot
    • 10.3.4. Operating business segments
    • 10.3.5. Product portfolio
    • 10.3.6. Key strategic moves and developments
  • 10.4. Capricorn Scientific
    • 10.4.1. Company overview
    • 10.4.2. Key executives
    • 10.4.3. Company snapshot
    • 10.4.4. Operating business segments
    • 10.4.5. Product portfolio
  • 10.5. Thermo Fisher Scientific Inc.
    • 10.5.1. Company overview
    • 10.5.2. Key executives
    • 10.5.3. Company snapshot
    • 10.5.4. Operating business segments
    • 10.5.5. Product portfolio
    • 10.5.6. Business performance
    • 10.5.7. Key strategic moves and developments
  • 10.6. AddLife
    • 10.6.1. Company overview
    • 10.6.2. Key executives
    • 10.6.3. Company snapshot
    • 10.6.4. Operating business segments
    • 10.6.5. Product portfolio
    • 10.6.6. Business performance